Skip to main content
Premium Trial:

Request an Annual Quote

Informax Expands into Massachusetts

NEW YORK, Dec 12 – InforMax announced Tuesday the opening of an office in Cambridge, Mass.

Informax said that the new office would serve as a sales and support site and will aim to introduce InforMax’s products to potential customers in the Northeast.

" Boston has emerged as one of biotechnology's capital cities," said Alex Titomirov, CEO and chairman of InforMax. " Staking our presence in this area allows InforMax to better satisfy our clients in the Northeast corridor and provide them with our signature customer support."

InforMax said it is also opening other offices in San Francisco and San Diego.

The company said that its products are used by more than 1,300 research organizations and more than 20,000 scientists worldwide. The company includes 19 out of the top 20 pharmaceutical companies among its customers.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.